avelumab
Showing 1 - 25 of 171
Avelumab in Real-World Treatment for Advanced or Metastatic
Not yet recruiting
- Bladder Cancer
- Avelumab
- (no location specified)
Nov 21, 2022
Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)
Not yet recruiting
- Breast Cancer
- Avelumab
- +2 more
- (no location specified)
Feb 2, 2023
Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)
Not yet recruiting
- Advanced Urothelial Carcinoma
- copanlisib
- Avelumab
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023
Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)
Active, not recruiting
- Lymphomas Non-Hodgkin's B-Cell
- Avelumab
-
Ballarat, Victoria, Australia
- +2 more
Jan 30, 2023
Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)
Active, not recruiting
- Breast Cancer
- Talazoparib
- Avelumab
-
Washington, District of Columbia
- +1 more
Oct 10, 2022
Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)
Active, not recruiting
- Urothelial Carcinoma
- Avelumab
- Docetaxel
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 18, 2022
Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)
Active, not recruiting
- Leptomeningeal Metastases
- Leptomeningeal Disease
- Avelumab
- Whole Brain Radiotherapy
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022
Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)
Active, not recruiting
- Sarcoma
- +6 more
- DCC-3014
- Avelumab
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 26, 2022
Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Meningioma
- Meningioma, Adult
- Avelumab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 27, 2022
Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)
Recruiting
- Recurrent or Metastatic NPC
- Axitinib
- Avelumab
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022
POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)
Terminated
- POLE Exonuclease Mutant Colon Cancer
- +2 more
- Avelumab
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Oct 5, 2022
Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML
Recruiting
- Non Small Cell Lung Cancer
- Solid Tumor
- Avelumab
- +3 more
-
Jette, Brussels, Belgium
- +1 more
Sep 9, 2022
Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)
Not yet recruiting
- Hepatocellular Carcinoma
- Axitinib
- +2 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Jun 27, 2022
OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE
Recruiting
- Urothelial Cancer
- Avelumab
-
Bristol, United Kingdom
- +9 more
Jan 23, 2023
Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)
Not yet recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- Axitinib
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 27, 2022
Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)
Completed
- Metastatic Colorectal Cancer
- RAS Wild Type
- Avelumab
- Cetuximab
-
Napoli, ItalyUniversità della Campania Luigi Vanvitelli
May 4, 2022
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Avelumab
- Cetuximab
-
London, United KingdomUniversity College Hospital
May 17, 2022
Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8
Recruiting
- Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Avelumab
- +2 more
-
Orange, California
- +10 more
Jan 30, 2023
Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)
Terminated
- Clear-Cell Renal Carcinoma
- rhIL-15
- Avelumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 27, 2022
SOGUG-AVELUMAB_RWD
Recruiting
- Metastatic Urothelial Carcinoma
- Avelumab
-
Vigo, Pontevedra, Spain
- +21 more
Jan 17, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
- Palbociclib
- Avelumab
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Urothelial Carcinoma Trial (Avelumab)
Not yet recruiting
- Urothelial Carcinoma
- Avelumab
- (no location specified)
Oct 26, 2022
And Use Of Avelumab In Combination With Axitinib For Treatment
Recruiting
- Advanced Renal Cell Carcinoma
- avelumab
- axitinib
-
Sandwich, Kent, United KingdomPfizer Ltd
May 23, 2022